Diguang International Development Co., Ltd. disclosed today that it plans to participate in the China Hi-Tech Fair (CHTF). The CHTF will run from Nov. 16-21, taking place at the Shenzhen Convention & Exhibition Center. DGNG will hold a press conference the day the fair opens (at 14:00 pm China time) regarding emerging LED TV technology, and how the Company will grow the LED market to $100 billion.

DGNG has a well-developed relationship with its family of subsidiaries, whereby it develops and manufactures cold cathode fluorescent lamps (CCFL’s), and light emitting diodes (LED’s) as backlighting elements for thin film transistor (TFT) and LED products. Such backlighting is a light source for liquid crystal displays (LCD’S), but the technology has applications throughout many different kinds of technology products, from digital cameras to home appliances. DGNG also has a small but lucrative foothold in energy-saving technologies for products associated with its general field of

...

Biomagnetics Diagnostics Corp. is an advanced medical device and biotechnology company with a revolutionary diagnostics system and test kit testing technology for HIV, Hepatitis, H-Pylori, HPV, Tuberculosis and many other viruses, bacterium’s, toxins and diseases. The company focuses on real-time testing for the actual presence of the virus/ toxin/ disease itself, instead of the antibodies produced by the body’s immune system which may take anywhere from weeks to months to appear.

The company intends to follow the lead of established Western drugmakers and biotechs Merck & Co. (MRK), Wyeth (WYE), Eli Lilly & Co. (LLY), Schering-Plough (SGP), Novartis (NVS), Sanofi-Aventis (SNY), Genentech (DNA), Bristol Meyers Squibb (BMYS) and many others that are ramping up investments in China, India and Singapore. The company is currently working to establish a separate Chinese operating company that it intends to apply for listing on the Shenzhen or Hong Kong stock exchange.

Biomagnetics is also currently

...

 

A new ETF giving access to Chinese A shares is to be launched in Singapore next month.

The United FTSE Xinhua China A50 ETF, to be offered by the asset management subsidiary of United Overseas Bank (UOB), will be the first China A-shares fund to be denominated and traded in Singapore dollars.

Chinese A shares are denominated and traded in Chinese yuan and listed on the Shanghai or Shenzhen stock exchanges. Historically, access to the A-shares market in China has been limited to Chinese nationals and qualified foreign institutional investors (QFIIs) approved by the China Securities Regulatory Commission (CSRC).

The FTSE Xinhua China A50 Index is designed to measure the performance of the 50 largest China A-shares companies, based on market capitalization.

ETFs tracking A shares are already dominant in the Asian market. The Hong Kong-listed iShares Asia Trust, which also tracks the FTSE Xinhua A50 Index, is the largest Asian ETF, with $6.7

...

Harman International Industries Incorporated (HAR) is seeing significant growth opportunities in Asian markets, particularly China and India. President, Chairman and CEO Dinesh C Paliwal recently stated that the company expects its earnings from China to exceed $1 billion over the next five years. Revenue from India is expected to reach $250 million during the same time period.  Management also announced the opening of a new R&D center in the Huang Pu commercial district of Shanghai yesterday, which is expected to complement its existing manufacturing facilities in Suzhou and Shenzhen. We think this is an effective way of reducing costs, as R&D engineers typically command higher pay than manufacturing personnel. The company’s current workforce in China is approximately 1000.  Simultaneously, the company launched its latest generation, scalable automotive infotainment system, which has been designed over the past year in Asia, Europe and the US. The product will ...

Solar Power Inc. designs, distributes and installs complete photovoltaic (PV) solar systems for customers in the United States. The company also sells their solar modules and system components to installers and distributors for use throughout Asia and Europe. Solar Power’s unique brand of photovoltaic modules and system components are manufactured at the company’s factory located in Shenzhen, China.

The company’s business strategy is to develop, manufacture and market solar panels and system component products as a complete photovoltaic system to industrial, commercial and residential facilities located primarily in the United States. Solar Power also brings their products to market through strategic company-owned retail operations and the national Yes! Solar Solutions franchise network that the company is currently building.

Solar Power Inc. announced today that it has entered into definite agreements with institutional and accredited investors with respect to a private placement of the company’s stock. The placement is expected to have

...

EI Du Pont Nemours Co. (DD), the world’s second largest chemical company, recently announced that it will benefit from the recovering economies in emerging markets including China, India and Brazil, where a significant increase in population and globalization are fueling demand.

DuPont sales in emerging markets have grown by 80% in the past five years at a compound annual growth rate (CAGR) of 16% and accounted for nearly one-third of the company's $30.5 billion sales in 2008. While 2009 emerging market sales estimates are expected to drop about 10% from $9 billion in 2008, the company projects 2012 emerging market sales of about $13 billion.

DuPont’s sales in China grew at a CAGR of 14% over the last five years. Sales in 2008 were about $1.7 billion. The company expects solar and light-weight vehicle technologies to help growth in China. The company is currently a major supplier to the crystalline silicon

...

The Top 10 Reasons Why the China Sell Off Will Continue

by Louis Basenese, Advisory Panelist

How much are you willing to pay for good advice? And by “good,” I mean profitable.

A couple of hundred bucks? A couple of thousand?

Before you answer, consider this: Two weeks ago, I alerted members of The Oxford Club to the precarious position of Chinese equities. As I put it, “China could be on a crash course with a correction.”

A contrarian stance, no doubt. But vindication came quickly.

The following Monday, Chinese stocks (represented by the Shanghai Composite Index) suffered a 5.8% drop – the worst single-day decline of the year. Two days later, they got dented by another 4.3%.

Unabashed China bulls will point out that the Shanghai index promptly recovered. But then this week hit…

Rally Rebuffed: Chinese Stocks Take Another Tumble

On Monday, the

...

If you want a stable dividend, focus on global companies. Dividends still matter. But you have to know where to look.

A record setting 367 companies reduced their dividends during the second quarter, no doubt leading many shell-shocked investors to conclude that income is dead.

But there’s more to this story. A total of 283 companies actually said that they boosted their payouts, and an even-larger group of companies maintained their current dividend payouts, Standard & Poor’s Inc. reported.

Not surprisingly, each of the two groups of companies featured some defining characteristics. The companies that had cut their dividends were largely domestic in nature, or at least had a decidedly domestic emphasis. By and large, the firms that were able to maintain or even boost their quarterly payouts were internationally focused, with the potential for some explosive business growth in the world’s key emerging economies.

A ...

Aeon has commenced trial operation of a new Jusco store in Xinzhou village, Shenzhen. This store is reported to be the seventh Jusco outlet opened by Aeon Shenzhen and is also the company's first community store in Shenzhen. With an area of about 18,000 square meters, the new Jusco Xinzhou store will provide foods imported from South [...]

Hard to Treat Diseases, Inc.

(Public, PINK:HTDS)

With the upcoming flu season upon us (considered between October and May with the peak of the season falling between late December and March), StocksHaven Investments highlights one of the most undervalued pink sheet penny biomedical stocks available, which not only tackles influenza treatments, but also many other harmful and dangerous viruses and infections. Hard to Treat Diseases is unlike any other company we have profiled before — rather than concentrating and manufacturing its own drugs for research and development purposes, it focuses on being a parent company for two subsidiaries: Slavica Bio Chem Co. and China Mellow Hope Inc.

About

The company operates 2 medical subsidiaries in Serbia, Europe and Mainland ChinaHTDS is a parent co with operations in a East European medical company (Serbia) Slavica Bio Chem Co (formerly ReNuYu

...